Dear Alumni,
Welcome to the Stanford Medicine Alumni Association website. I am honored and humbled to take up the baton as the current President of SMAA, and I look forward to working with you to further SMAA’s mission to reach, inspire, serve, and engage our alumni (RISE). I welcome each one of you to engage and reengage as an integral part of the SMAA family, connecting with classmates, mentoring our current students and trainees, volunteering for our communities, and building friendships through various educational conferences, sporting events and social gatherings.
I encourage you to visit this website to learn of programs and services we provide throughout the year. If you have additional comments or questions, we would love to hear from you. Click here for our contact information and let us know if we can make the SMAA community event more engaging, inclusive, diverse, and fun!
Best regards,
Volney F. Van Dalsem III, BA ’71, MD ’75
President
Stanford Medicine Alumni Association
Board Officers
Volney (Vol) F. Van Dalsem III
BA ’71, MD ’75
PRESIDENT
Dr. Van Dalsem III has had a long engagement with Stanford University, receiving his BA in Biology in 1971 and M.D. in 1975. He completed his internship, residency and fellowship in Diagnostic Radiology at the University of California, San Francisco in 1980, where he continues to serve on the Diagnostic Radiology Margulis Society Alumni Board of Directors.
Dr. Van Dalsem practiced Diagnostic Radiology at El Camino Hospital in Mountain View, California from 1980 through 2007, and has served as the Medical Director of the Radiologic Technology and Diagnostic Medical Sonography Training Programs at Foothill College since 1991. In 2007, he returned to Stanford Medical School as an Associate Professor, Clinical Educator faculty member and Medical Director of Outpatient Imaging for Stanford Hospital and Clinics. He was appointed Professor of Abdominal Imaging in the Stanford Department of Diagnostic Radiology in 2012.
Dr. Van Dalsem has been a member of the Board of Governors of the Stanford Medicine Alumni Association since 2014, and is currently president of the association.
Arturo Molina
MS ’83, MD ’83, PD ’86, PD ’89
PAST PRESIDENT
Dr. Molina is Chief Medical Officer at Sutro Biopharma. Previously, he was Vice President, Oncology Scientific Innovation at Janssen R & D (Johnson and Johnson, JNJ). While at JNJ he was responsible for the clinical development and New Drug Application for abiraterone (Zytiga®), which is now approved for metastatic prostate cancer in more than 100 countries. He was Chief Medical Officer/EVP at Cougar Biotechnology, which was acquired by JNJ in 2009. Arturo also worked at IDEC, then Biogen-IDEC, ultimately becoming Head, Oncology Clinical Development. In collaboration with Genentech, he led the clinical Supplemental Biologics License Application (sBLA) filing activities resulting in FDA approval of Rituxan® in two first-line indications in 2006: follicular lymphoma and diffuse B-cell lymphoma.
From 1991-2002, Dr. Molina was a faculty physician in Hematology/Bone Marrow Transplantation and Medical Oncology/Therapeutics Research at the City of Hope (COH) Comprehensive Cancer Center, where he became an Adjunct Professor, member of the COH Medical Group Board of Directors and President-Elect of the COH Medical Staff. Arturo received his MD and MS (Physiology) from Stanford University, and completed residency in Internal Medicine and fellowships in Medical Oncology, Biological Science, and Bone Marrow Transplantation, all at Stanford.
Arturo was an undergraduate at the University of Texas at Austin where he received a BS in Zoology (Honors) and BA in Psychology (High Honors).
Deval Laskhari
PHD ’96
PRESIDENT - ELECT
Dr. Lashkari has worked in the life sciences area developing and commercializing novel technologies. During his time as a graduate student, Dr. Lashkari worked at the Stanford Genome Technology Center on new technologies used in the human genome project. He was also President of BioMASS and was involved with summer research programs for minority undergraduate students. After completing his PhD in Genetics, he became a founding research director for a genomics tools company. He gained corporate and business development experience through senior management positions in a number of life science businesses. Dr. Lashkari is a co-founder and Senior Partner at Telegraph Hill Partners, a San Francisco based life sciences and healthcare venture capital firm and works closely with innovative healthcare companies.
Lisa Zaba
BS ’00, RESIDENT ’13, PD ’13
SECRETARY
Dr. Zaba has had a variety of experiences in scientific academia, medical academia, and biotech and is currently a Clinical Associate Professor of Dermatology at Stanford. Dr. Zaba received her undergraduate degree from Stanford University (’00) in Biology then completed an MD/PhD and internship at the Cornell/Rockefeller/Memorial Sloan-Kettering Tri-institute (’10), with a focus on immunology. She is best known in the scientific community for elucidating the pathophysiology of psoriasis, a common skin condition, which paved the way for specific antibody based therapeutics that now treat this disease. She subsequently returned to Stanford Medical School for a residency in Dermatology (’13) with a focus on complex immunologic diseases that have skin manifestations, and also completed a post-doc in Genetics. After her post-doc she worked for Alector biotech company as the Director of Immunology, and then 3 years as the Director of Complex Medical Dermatology for Northern California Kaiser. She is now the Director of Cutaneous Oncology at the Stanford South Bay Cancer Center.
Jennifer Cauble
BA ’76
EXECUTIVE DIRECTOR, ALUMNI RELATIONS
Jennifer serves as the Director of Alumni Relations for Stanford’s Medical Center and Executive Director of the Stanford University Medical Center Alumni Association. She has a strong connection to Stanford as an alumna, Stanford parent, long-serving volunteer and staff member. She has worked on projects across campus including planning numerous alumni events, serving as a consultant at the School of Architectural Design and working with the Office of Technology & Licensing.
Trained in classical marketing Jennifer has over 25 years of experience in the private sector building teams and marketing programs for nationally recognized brands and consumer electronics start-ups. In the non-profit sector, Jennifer has worked at a variety of universities creating multidimensional programs that increase awareness, enhance engagement and help organizations deliver exceptional value. She is the past Director of Marketing and Membership for Stanford’s Alumni Association, former consultant to the International Business School at Brandeis University, and also served as Associate Vice President of Marketing and Communications at San Jose State University.
Board Members
Shelley Force Aldred
PhD ’05
Shelley Force Aldred is CEO and Co-founder of Rondo Therapeutics, a preclinical stage biopharmaceutical company developing bispecific therapeutic antibodies that enable controlled activation of the immune system to fight cancer. Previously, Dr. Force Aldred served as VP for Preclinical Development at TeneoBio, a highly successful multispecific therapeutic antibody company. She was part of the formation of TeneoBio and led the preclinical efforts creating a CD3xBCMA bispecific antibody, from product concept to IND-ready package. Dr. Force Aldred was formerly director of worldwide R&D for Active Motif following the acquisition of SwitchGear Genomics in 2013. In 2006, she co-founded SwitchGear Genomics, a venture-backed functional genomics platform company, and she served as its COO and Board Member. Prior to founding SwitchGear Genomics, Dr. Force Aldred was a Scientific Director on Stanford’s ENCODE Project and received her Ph.D. from Stanford University.
Jane Binger
BS ’73, MA '80, ED '82
Dr. Binger has dedicated her career to the intersection of education, healthcare, and breaking barriers so college students and healthcare professionals of all backgrounds can reach their professional dreams.
Presently, Jane is Co-Founder and Chief Learning Officer of DeepTok, a Foundation for California Community Colleges non-profit; Senior Advisor, Center of Excellence in Diversity in Medical Education, Stanford Medicine; Diplomat, University of California Merced Foundation where she co-sponsors the Grad Slam Research Presentation Competition; and an Executive Board Member, California Medicine Coalition. Previously, she was a Senior Research Officer, Sutter Health, where she led teams that developed the first system-wide strategy for research, personalized medicine, and graduate medical education. She was Executive Director, Physician Leadership Education, Lucile Packard Children’s Hospital Stanford for nine years.
Dr. Binger enjoys volunteering for the National Hispanic Medical Association Annual Conference Committee, Napa Valley College MESA/STEM Center Advisory Board, and Stanford University as an undergraduate admissions alumni interviewer. She earned her BS, and MA and Doctorate in Education from Stanford University, and MS from UCSF.
Gabriel Brat
MD ’08
Gabriel Brat is a trauma surgeon and assistant professor of bioinformatics at Harvard Medical School and Beth Israel Deaconess Medical Center. He is also the co-founder of Tissue Analytics, a platform that leverages machine learning and computer vision to transform wound care. He teaches courses in health IT innovation at the medical school and mentors and advises healthcare and digital startups. He is passionate about the intersection of surgical innovation and digital health and has published and patented numerous mechanical and digital tools to improve surgical outcomes. Gabriel has an undergraduate degree in bioengineering and a graduate degree in public health and biostatistics from the London School of Hygiene and Tropical Medicine. He completed his medical training at Stanford University and his surgical residency at Johns Hopkins Hospital.
Grace Chang
MD ’06
Dr. Chang is the Chief Medical Officer of Oxurion NV, a biotech company developing innovative treatment therapies for retinal disease. Prior to this she was the Chief Medical Officer at Notal Vision Inc., developing AI-enabled, home-based monitoring of retinal disease. She is also a practicing vitreoretinal surgeon at the University of Southern California, and was previously a full-time member of the faculty at the University of Washington. She received a bachelor’s degree in Chemistry from Stanford, followed by a master’s degree in Electrical Engineering, also at Stanford. She then obtained her Ph.D. degree in Computation and Neural Systems at the California Institute of Technology, and subsequently returned to Stanford for her M.D. During that time, she was Chair of the Graduate Student Council, and successfully led the advocacy efforts for the building of the Graduate Community Center, as well as for subsidized health care for the Stanford graduate population. She completed both her ophthalmology residency and vitreoretinal fellowship at Harvard Medical School/Massachusetts Eye and Ear Infirmary. Her other avid interests include cooking, the arts, and travel.
Mark Ping Chao
MD '08, PhD '11, Fellow '14, Resident '16
Dr. Mark Chao is a physician-scientist, hematologist and biotechnology entrepreneur with a focus in oncology and regenerative medicine research. He is currently co-founder and CEO of TenSixteen Bio, a precision therapeutics platform company. Mark previously served as Vice President of Oncology Clinical Research at Gilead Sciences. Prior to that, Mark was co-founder and Senior Vice President of Clinical Development at Forty Seven, Inc., an immuno-oncology company developing first-in-class macrophage-directed therapeutics which was acquired by Gilead Sciences for $4.9B in 2020. As one of the scientific pioneers discovering CD47 as a target in cancer, Mark helped lead research from lab discovery through late-stage clinical development. Mark was named one of the 20 under Forty in biopharma leaders by Endpoints News. He has broad interests in translational research, clinical development and biotechnology company formation.
He received his medical degree, PhD in cancer biology and internal medicine and hematology training at Stanford University. He serves on the board of directors for Hepatx Corporation, the Northern California Chapter of the Leukemia Lymphoma Society and on the scientific advisory boards of TigaTx and IconOVir Bio. He and his wife Alice (BA ’99, PhD ’09) are proud Stanford alumni and have three young children.
Peter Yee-Chew Chiu
MD ’83
Dr. Peter Y. Chiu is an Emeritus Adjunct Clinical Professor of Medicine at Stanford University and has been very active in the Stanford MD Admissions Program and the First-Generation Mentorship Program of Stanford Medicine. Since 2013 he has been on the Bay Area Air Quality Management District (BAAQMD) Hearing Board that serves to adjudicate regulatory compliance issues that may arise between the BAAQMD and local industries. Previously, he practiced as an Occupational Medicine Department and Emergency Department physician at Kaiser Milpitas/Santa Clara from 1990 to 2011 and as a Family Medicine physician in San Jose from 1986 to 1990. Additionally, he was appointed by President Clinton to serve on the US Presidential/Congressional Environmental Risk Assessment and Risk Management Commission from 1994 to 1997. Prior to his career in medicine, Dr. Chiu was a principal environmental engineer for the Association of Bay Area Governments from 1976 to 1979. He received his MD degree from Stanford University and his BS, MPH and DrPH degrees from the University of California, Berkeley.
Hudson Horn
PhD Candidate, Student Representative
Hudson received his B.S. in Molecular Biology at the University of Wisconsin – Madison in 2020 before joining the Stanford Cancer Biology program. He is currently a NSF GRFP Fellow and is conducting his thesis work in Dr. Calvin Kuo’s lab where he is studying thyroid carcinogenesis using organoid models. Specifically, Hudson is using genetic engineering techniques to advance normal human thyroid organoids he has derived into the different stages and types of thyroid cancer to model carcinogenesis. Following graduation, Hudson would like to join an early stage biotech company to help bridge the gap between scientific discovery and patient treatments. Outside of the lab, Hudson likes to hike and explore the many different cuisines the bay area offers.
Lauren (Lojo) Joseph
MD Candidate '22
Lauren (LoJo) Joseph is a California native, born and raised near Los Angeles. She earned her B.A. in Human Biology at Stanford. After a year working in clinical research at UCSF, she began the Stanford MD program in the fall of 2018. In medical school, she pursued her passion for writing and wrote stories for Scope, Stanford Medicine's blog, and began editing Anastomosis. She spent a research summer working as a science journalist at STAT News and continues to submit stories for publication. She hopes to make journalism and writing a big part of her future career. Having completed a year of clinical rotations, she is eager to build more connections and community between students and alumni as an MD representative in SMAA.
Bernd Kutzscher
’71, MD ’80
Dr. Kutzscher is a 34-year boarded private practice ophthalmologist, and now Chief of Comprehensive Ophthalmology, California Pacific Medical Center, San Francisco as well as Associate Clinical Professor, Dept of Ophthalmology at UCSF. For three decades he has served as an international & local volunteer eye surgeon for those in need with groups such as Hospital de la Familia, San Marcos, Guatemala; Orbis International (Flying Hospital), Surgical Volunteer, Vietnam; Clinic by the Bay (free San Francisco clinic) and Rotacare Free Clinic, Seton Medical Center (Co-Founder). He has served on the American Academy of Ophthalmology, Public Information Committee, and has been an SUSOM Ophthalmology instructor as well as serving on the Stanford Medical Staff in Ophthalmology. He is an American Academy of Ophthalmology, Fellow, 1990 and was American Board of Ophthalmology, Board Certified, in 1989. He is married to Marilyn Kutzscher, MD and they have three children who have pursued careers in medicine. He loves whitewater rafting, downhill and cross-country skiing, bicycling, and the San Francisco ballet and symphony.
Kimberly Lee
’97, MD ’03
Dr. Lee is an otolaryngologist/facial plastic and reconstructive surgeon in private practice in Beverly Hills, CA. She is an Assistant Clinical Professor in Head and Neck Surgery at UCLA and Attending Physician at Cedars-Sinai Medical Center. She graduated from Stanford University with Honors in Biological Sciences and Honors in Humanities, as well as Phi Beta Kappa and Academic Distinction, and was awarded the prestigious Dinkelspiel Award for her contributions as a campus leader while at Stanford. Dr. Lee completed her MD degree at Stanford followed by residency in Otolaryngology/ Head and Neck surgery at UCLA, where she was Chief Resident. Dr. Lee completed her fellowship training in Facial Plastic and Reconstructive Surgery. Dr. Lee has over a decade of hands-on clinical experience including establishing and managing a medical practice, training other plastic surgeons and injectors as a national trainer on behalf of pharmaceutical companies Galderma and Allergan, serving as a clinical advisor for medical device companies, and serving as a medical expert for numerous media outlets. She is a Committee Member for both the Women in Facial Plastic Surgery and Face to Face, a pro bono organization through the American Academy of Facial Plastic and Reconstructive Surgery dedicated to assisting victims of domestic violence. In addition to her professional accomplishments, she is an avid golfer who enjoys traveling, the fine arts, and spending time with her twin sons.
Simone Marticke
PhD ’08
Simone Marticke grew up in a small village in the former East Germany. Eventually, after moving to California as au-pair, she completed her BS in Biological Sciences and her PhD in Genetics at Stanford University. Her career began in the non-profit sector, managing cancer early detection research programs for Canary Foundation in Palo Alto. She then joined the life sciences practice of a business strategy management consulting firm. Her subsequent career trajectory bridged strategy and execution in life science tools at Agilent Technologies and cancer diagnostics at Biocartis. Currently, Dr. Marticke is Deputy Director of Strategy, Planning, and Management for the Discovery & Translational Sciences team at the Bill and Melinda Gates Foundation in Seattle, Washington. This team is tasked with catalyzing innovation toward transformative solutions to global health and development inequity, including drugs, vaccines and human immunobiology, and reproductive health technologies. This role draws on her multifaceted experience in strategy, operations, and science, and applies it toward solving some of the world’s most pressing problems.
Mark Michalski
MD ’10
Mark H. Michalski, MD, is the World Wide Head of Business Development for HCLS AI/ML at Amazon/AWS. Previously he launched the Center for Clinical Data Science at Mass Gen Brigham, which is focused on the application and translation of novel machine learning techniques into clinical practice. Previous to this role, Dr. Michalski held leadership and operational roles at early-stage companies in the medical software and device domain, including Butterfly Network and Hyperfine Research. Dr. Michalski held additional strategic roles in healthcare-focused efforts at Google and Genentech. Dr. Michalski completed his radiology residency training as a Holman Fellow at Yale-New Haven Hospital. He graduated with a degree in Cybernetics from the University of California at Los Angeles with multiple honors and received his medical degree from Stanford University.
Jessica Ngo
MD ’05
Jessica Ngo is board certified in Emergency Medicine, fellowship trained in Emergency Medical Services and Disaster Medicine, and certified in Wound Care and Hyperbaric Medicine. She completed her undergraduate degree from University of Pennsylvania, then transplanted to the west coast where she completed medical school, residency and fellowship at Stanford University. She served as an attending physician and Assistant Professor of Emergency Medicine at Stanford University for 12 years.
Dr. Ngo has a passion for disaster response as well as education. She served on the Stanford Hospital Disaster Planning Committee Board, then co-founded Stanford’s first disaster deployment team named SEMPER, Stanford Emergency Medicine Program for Emergency Response. She has directed numerous disaster responses around the world, starting with the 2010 Haiti earthquake. She developed the drive-through medicine model, which has since been published and adapted around the world for Covid-19 testing and vaccinations. For over a decade she was very involved in Stanford medical student education, as Director of the Emergency Medicine Clerkship, Medical School Procedure Course and Stanford EMT Course. Dr. Ngo transitioned to the Palo Alto Veteran’s Affair hospital Emergency Department as their disaster expert.
Ethan Nicholls
MD ’88
Dr. Ethan A. Nicholls received his A.B. from Harvard University, his M.D. from Stanford University and completed his Anesthesia residency and fellowship in Pain Management at the University of California, San Francisco (UCSF).
He joined the Palo Alto Foundation Medical Group in March 2015 where he currently serves as Chair of the Department of Anesthesia, Alameda Division. Previously, he was a senior partner and served as President of Northern California Anesthesia Associates (2004-2015). After completing his residency and fellowship training, Dr. Nicholls held the position of Assistant Professor of Anesthesiology and Pain Management at the University of California, San Francisco before leaving for private practice and working at El Camino Hospital, and later Washington Hospital.
In addition to his clinical practice, Dr. Nicholls has served in numerous other roles. Most recently on the Board of Trustees, Castilleja School in Palo Alto (2011-2017). He served as a Delegate, District 4, California Society of Anesthesiology (2001-2007) and previously held multiple staff and committee positions at El Camino Hospital including Chief, Department of Anesthesiology.
Dr. Nicholls has two daughters, is a Stanford Women’s Basketball season ticket holder and enjoys traveling and attending the theatre and SF Opera.
Santiago Enrique Sanchez
MD/PhD Candidate, Student Representative
Santiago is a fourth-year MD/PhD student at Stanford. Originally from Barquisimeto, Venezuela by way of Houston, Texas, he is an aspiring physician-scientist in the Cancer Biology program and advised by Steven Artandi. In the past, he served on the executive committee of the Latinx Medical Students Association, President of the Stanford Medical Students Association, and now as alumni representatives for the medical student body on the Alumni Board of Governors.
Thomas Satterwhite
’00, MD ’04
Dr. Thomas Satterwhite obtained his bachelor’s degree (Human Biology with Honors) and Medical Degree at Stanford University. He remained at Stanford Hospital to complete his residency in Plastic & Reconstructive Surgery. His expertise in facial surgery was further refined with the completion of a craniofacial fellowship in Miami, FL under the tutelage of Dr. S. Anthony Wolfe. Dr. Satterwhite has presented nationally and internationally in plastic, reconstructive, craniofacial, and gender affirming surgery with more than 80 podium presentations over the years; and he has authored more than 50 peer-reviewed research articles and book chapters. He’s heavily engaged in numerous international and national organizations including the World Professional Association for Transgender Health and the American Society of Plastic Surgeons. He is a peer reviewer for several well-respected journals including the Journal of Plastic and Reconstructive Surgery and the Journal of Aesthetic Surgery. Dr. Satterwhite performs the full spectrum of gender affirmation surgical care in a private practice setting in San Francisco, CA since 2014 where he and his partner physicians at Align Surgical Associates provide comprehensive care in all aspects of gender affirming surgery for transmen, transwomen, non-binary, and gender diverse individuals.
Anjali Shastri
PhD ’13
Anjali has more than 10 years of experience advancing biomedical research programs and policy in industry, academia, and government. Currently, as a Program Manager at 23andMe, Dr. Shastri manages research projects and collaborations with academic and industry partners to further genomics research and improve the products and services 23andMe provides its customers.
Dr. Shastri previously served as a Policy Advisor in the Office of Global Health Diplomacy at the U.S. Department of State. There she worked across U.S. government agencies, NGOs, and international partners to strengthen countries’ capacity to combat disease, improve healthcare for vulnerable populations, and equip diplomats to engage in health diplomacy. She also worked at the U.S. Department of Health and Human Services’ Office of Global Affairs, where she coordinated global health policy for Asia.
She received her Ph.D. in Immunology in 2014 from the Stanford University School of Medicine, where she studied how the parasite Toxoplasma gondii manipulates the host immune system. She obtained her bachelor’s degree from the University of California, Berkeley in Molecular and Cell Biology.
Throughout her career, Dr. Shastri has been passionate about increasing diversity in science. At Stanford, she was co-President of the Biomedical Association for the Interest of Minority Students and a Diversifying Academia Recruiting Excellence fellow; at 23andMe, she serves on the Diversity and Inclusion Leadership Committee.
Melissa Sims
MD ’07
Dr. Melissa Sims is currently a private practice radiologist with California Advanced Imaging Medical Associates (CAIMA) in Northern California. Dr. Sims graduated cum laude from Harvard University with an A.B. degree in Psychology. She received her M.D. from Stanford School of Medicine and M.P.H. from the University of California at Berkeley. She completed Radiology residency at UCLA and Stanford, after which she completed a fellowship in Musculoskeletal Imaging with National Orthopedic Imaging Associates. In addition to her clinical work, Dr. Sims is a contributor to the new editions of Stoller’s Orthopaedics and Sports Medicine textbooks. During her time at Stanford, she was President of the Stanford Medical Student Association and Coordinator for the Stanford University Minority Medical Alliance, a student organization dedicated to increasing diversity in medicine. Dr. Sims lives in San Mateo with her husband, Leroy (BS ’01, MS ’02, MD ’07, Fellow ’10), and their two young daughters. They enjoy international travel, supporting Stanford sports teams, cooking, and learning foreign languages.
Russell Stewart
BS ’01, MS ’01, MD ’09
Dr. Stewart was an undergraduate student athlete at Stanford and received his BS and MS in Biological Sciences in 2001. He returned to Stanford in 2010 to complete his residency and fellowship in Diagnostic Radiology and joined the faculty as an Assistant Clinical Professor in 2015. He served as the Director of Body Imaging at the South Bay Cancer and Director of Quality Management for the Department of Radiology until 2018.
Currently, Dr. Stewart splits his time as a practicing radiologist at Stanford and as the Vice President of Clinical Affairs at Nines, Inc, a startup company headquartered in Palo Alto looking to utilize advanced technology and machine learning to empower radiologists and improve patient care. He also continues to serve as an undergraduate pre-major advisor for incoming students at Stanford and maintains close ties with the Stanford Department of Athletics in helping recruit high school student athletes interested in careers in medicine.
Nathan Trinklein
PhD ’03
Nathan received his Ph.D. from Stanford in 2003 with a focus on functional genomics. After graduating, he served as the Technical Director of the Stanford ENCODE pilot project. Nathan began his career as a biotech entrepreneur by co-founding SwitchGear Genomics based on technology developed at Stanford. After the acquisition of SwitchGear, he was part of starting a therapeutics immuno-oncology company called Teneobio where he currently serves as the Chief Technology Officer. Teneobio employs a sequence-based approach for antibody discovery that leverages next-generation sequencing and high-throughput functionally assays to develop fully-human multi-specific antibodies. Dr. Trinklein has authored over 30 peer-reviewed publications and is an inventor on over 15 patents.
Raymond Tsai
MD ’13
Dr. Raymond Tsai is a Family Medicine physician working in California’s Central Valley. He currently provides executive medical leadership for a private company’s philanthropic mission to improve health outcomes for its agricultural workers and the communities in which they live. In this role, he oversees multiple interdisciplinary and innovative primary care clinics based in mostly rural and traditionally underserved areas in Central California. Raymond received his MD from Stanford in 2013, during which time he served his class for 4 years as Social Chair for Stanford Medical Student Association. He completed his residency in Family Medicine at UCLA and is also Board Certified in Clinical Informatics. Prior to medical school he obtained his B.A. in Music: Vocal Performance from UC San Diego, and MS in Health Policy and Management from Harvard T.H. Chan School of Public Health. Raymond has also worked at the World Health Organization, as well as in New Orleans establishing school-based health centers after Hurricanes Katrina and Rita. One of his favorite hobbies include carving pumpkins, which is a skill he cultivated as part of the anatomy lab competition at Stanford.
Alan Tung
PhD ’25 Candidate
Alan is a Lucille P. Markey Biomedical Research Fellow in the Stanford Cancer Biology PhD Program. He is enthusiastic about cancer biology, metabolism, and biotechnology. His interests led him to join Dr. Jonathan Long’s Lab to study the signaling role of circulating metabolites in cachexia, a deadly metabolic syndrome that leads to weight loss and anorexia in advanced cancer. Alan is passionate about biotech innovation and is an event organizer of the Bay Area Taiwanese Biotech Association (BATBA). In addition, he actively engages in outreach and diversity initiatives at Stanford Medicine. He is excited to contribute to the Stanford Medicine community by connecting alumni and Biosciences students.
David Walter
PD ’01
Dr. Walter is an experienced professional in the biopharmaceutical industry, with a wide variety of experience from early stage research to commercial manufacturing. He is currently working at Amunix Inc., where he is the Associate Director for Technical Operations working in Drug Product Development and Quality Assurance. Prior to Amunix, he held positions at leading biotechnology companies including Genentech/Roche, Bayer, MedImmune and Applied Biosystems. He has worked in research and development in areas such as cancer, immunology, neuroscience, vaccines, hematology and next generation sequencing. Recently he led the downstream Phase III clinical production of Tecentriq (Genentech’s new cancer immunotherapeutic).
Dr. Walter was a postdoctoral fellow at the Stanford University School of Medicine in the Department of Pediatrics from 1998 to 2001 after completing his Ph.D. in Molecular Biology at Princeton University. While at Stanford, he developed and characterized potential novel treatments for asthma in the laboratory of Dr. Dale Umetsu.
Monica Wiemer
BA ’00, MD ’06, MS ’15, Resident ’09, Fellowship '15
Dr. Monica Eneriz Wiemer is a practicing pediatrician at the Palo Alto Foundation Medical Group and chairs her medical group’s committee on diversity, equity, and inclusion. She is chair of the department of pediatrics at Good Samaritan Hospital in San Jose. Dr. Wiemer graduated from Stanford with a BA in Human Biology. She received her MD at Stanford and completed her pediatric residency at Lucile Packard Children’s Hospital. As a Stanford fellow in academic general pediatrics, she studied the impact of language and literacy barriers on children’s health outcomes and completed a MS in health services research.
As a Stanford medical student, Dr. Eneriz Wiemer served as president of the Stanford American Indigenous Medical Students, was an active member of the Latino Medical Student Association, and coordinated the Stanford University Minority Medical Alliance, a student organization dedicated to increasing diversity in medicine.